Alain Munoz

Physician qualified cardiology and intensive care he has over 30 years of experience in the industry at senior management level. Served as SVP for international development in the Sanofi Group and in the pharmaceutical division of Fournier Laboratories. He has been a member of the Scientific Committee of the French drug agency and Chairman of the Board of Hybrigenics SA and Novagali Pharma SA. He presently serves on the scientific advisory board of Valneva SA and in is an independent board member of Amryt Pharma plc (Nasdaq: AMYT), Auris Medical Holding AG (Nasdaq: EARS) and Zealand Pharma A/S (Nasdaq: ZEAL).